3 Big Pharma Stocks Wall Street Thinks Could Soar By At Least 30%
Many investors like to buy shares of large drugmakers for the relative stability that they provide. But tremendous growth often isn't expected from these stocks.
That doesn't mean, though, that strong growth is always out of the question for top biopharmaceutical companies. Here are three big pharma stocks that Wall Street thinks could soar by at least 30% within the next 12 months.
Image source: Getty Images.
Source Fool.com
